Absence of presurgical glucocorticoid therapy (OR 3.48; 95% CI 1.19-10.12) and lack of oral sodium repletion (OR 2.59; 95% CI 1.25-5.35) increased the risk of intraoperative hypertensive crisis.
Cohort (n=296)
Yes
What are the presurgical and surgical risk factors for intraoperative hypertensive crisis in patients undergoing resection of pheochromocytomas and sympathetic paragangliomas?
In patients undergoing surgery for pheochromocytomas and sympathetic paragangliomas, absence of presurgical glucocorticoid therapy, higher presurgical systolic blood pressure, larger tumor size, and lack of oral sodium repletion significantly increase the risk of intraoperative hypertensive crisis.
Effect estimate: OR 3.48 (95% CI 1.19-10.12)
PURPOSE: To identify presurgical and surgical risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas (PGLs) (PPGLs). METHODS: Retrospective multicenter cohort study of patients with PPGLs from 18 tertiary hospitals. Intraoperative hypertensive crisis was defined as systolic blood pressure (SBP) greater than 200 mmHg lasting more than 1 min and postoperative hypertensive crisis as SBP greater than 180 mmHg or diastolic blood pressure (DBP) greater than 110 mmHg. RESULTS: A total of 296 surgeries were included. Alpha presurgical blockade was employed in 93.2% of the cases and beta-adrenergic in 53.4%. Hypertensive crisis occurred in 20.3% ( n = 60) of the surgeries: intraoperative crisis in 56 and postoperative crisis in 6 cases (2 cases had both types of crises). We identified as risk factors of intraoperative hypertensive crisis, absence of presurgical glucocorticoid therapy (odds ratio OR 3.48; 95% confidence interval CI 1.19-10.12) higher presurgical SBP (OR 1.22 per each 10 mmHg, 95% CI 1.03-1.45), a larger tumor size (OR 1.09 per each 10 mm, 95% CI 1.00-1.19) and absence of oral sodium repletion (OR 2.59, 95% CI 1.25-5.35). Patients with hypertensive crisis had a higher rate of intraoperative bleeding ( P < 0.001), of intraoperative hemodynamic instability ( P < 0.001) and of intraoperative hypotensive episodes ( P < 0.001) than those without hypertensive crisis. CONCLUSION: Intraoperative hypertensive crisis occurs in up to 20% of the PPGL resections. Patients not pretreated with glucocorticoid therapy before surgery, with larger tumors and higher presurgical SBP and who do not receive oral sodium repletion have a higher risk for developing hypertensive crisis during and after PPGL surgery.
Araujo‐Castro et al. (Tue,) conducted a cohort in Pheochromocytomas and sympathetic paragangliomas (PPGLs) (n=296). Absence of presurgical glucocorticoid therapy (OR 3.48; 95% CI 1.19-10.12) and lack of oral sodium repletion (OR 2.59; 95% CI 1.25-5.35) increased the risk of intraoperative hypertensive crisis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: